slides · global inventory
Table
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 60,557
Current window 37,231-37,260
Pages 2,019
Rows per page 30
Component
37,231-37,260 of 60,557
26
The slide uses a map graphic as a background element to reinforce the 'International' theme.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
33
LSD = Low Single Digits, MSD = Mid Single Digits, HSD = High Single Digits. The chart visualizes the shift from 4-6% to 6-8% CAGR.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
35
Uses directional arrows to indicate impact on margins.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
43
Includes footnotes explaining COVID-19 related inventory costs and acquisition-related charges.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations 1 hit
44
Includes footnotes (1) through (6) referenced in the table rows.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations 1 hit
47
The table reconciles GAAP net income to non-GAAP adjusted net income by adding back various one-time or non-cash charges.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations 1 hit
49
Includes non-GAAP financial measure disclosure and specific footnotes regarding adjustments.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations 1 hit
06
The slide presents a snapshot of company growth from 2019 to Q2 2022, including instrument shipments, manufacturing capacity, market reach, and revenue.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
12
The slide uses a color-coded border system to distinguish between test types (Qualitative/Quantitative Immunoassay, Enzyme, Molecular).LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
15
LumiraDx | Investor Presentation Deck | 55 slidesLumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
26
The slide uses a bulleted list for key value propositions and a table to demonstrate clinical sensitivity (PPA) across different Ct value thresholds.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Evidence1 hit
27
The slide uses a blue dashed box to highlight key differentiators for the company's product.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Evidence1 hit
28
The scatter plot shows a high correlation (R^2 = 0.9868) between the two testing methods.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Evidence1 hit
29
The slide uses a process diagram to explain the workflow and a combination of line charts and a comparison table to demonstrate performance feasibility.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Evidence1 hit
30
The chart shows a significant drop-off in the TB care cascade, framing the opportunity for a POC test to improve linkage to care.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Evidence1 hit
33
The table shows a progression from Year 1 to Year 2, and a second Year 2 column, likely representing a ramp-up or optimization scenario.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
34
The slide uses a product-centric layout to demonstrate market readiness and addressable market size for a portfolio of diagnostic tests.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
35
The slide uses a Gantt-style chart to visualize development stages (Concept to Regulatory) for multiple product lines.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
36
The slide uses a color-coded legend to distinguish between testing methodologies (Immunoassay, Molecular, Enzyme, Metabolic/Electrochemical).LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
42
The diagram is a circular process flow showing the integration of hardware, software, and pharmacy services.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
45
The slide uses a matrix structure to segment the market and align products/partners to each segment.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
46
Includes a table of use cases and a bar chart of instrument counts.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
51
The table tracks cumulative instruments, manufacturing capacity, geographic reach, and revenue breakdowns.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
04
The table uses checkmarks for completion and various X marks to denote 'No Interest' or 'Re-confirmed no interest' post a specific filing event.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
05
Includes redacted information regarding specific entities and dates.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
06
Includes volume data and specific event markers leading up to the unaffected date of 9/16/2022.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
07
Market data as of 9/27/2022.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
08
Includes specific callouts for 'Unaffected', 'Violet IOI', 'Violet Revised IOI 1', and 'Orange Counter Proposal 1'.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
10
The slide is heavily redacted. It includes a red dashed box highlighting a specific column and a red circle around a cell in that column.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
11
The slide uses a table to compare rollover percentages and amounts across three scenarios for various investors.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit